Judge Enjoins Pharmaceutical Company From Pursuing Arbitration In Switzerland

Judge Enjoins Pharmaceutical Company From Pursuing Arbitration In Switzerland

CHICAGO - An Illinois federal judge on July 19 granted a Delaware company's request for permanent injunction and declaratory relief, finding that as a nonsignatory to a license agreement for the marketing and sale of a pharmaceutical in the United Kingdom, it was not required to arbitrate claims against a Netherlands entity before the International Chamber of Commerce (ICC) (Hospira Inc. v. Therabel Pharma N.V., No. 12-8544, N.D. Ill.; 2013 U.S. Dist. LEXIS 102196).

Find full version on lexis Advance®
Access this news story on lexis.com®